Published in Syst Rev on June 14, 2016
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (2015) 9.65
Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol (2013) 4.05
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health (2011) 3.88
Acute-on chronic liver failure. J Hepatol (2012) 3.74
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ (2009) 3.18
Surgery and portal hypertension. Major Probl Clin Surg (1964) 3.16
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells (2006) 2.77
Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med (2010) 2.38
Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol (2004) 2.16
Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol (2014) 2.15
Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin (2013) 2.10
Indirect comparisons: a review of reporting and methodological quality. PLoS One (2010) 1.65
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med (2010) 1.53
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol (2008) 1.52
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol (2006) 1.43
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol (2007) 1.39
Ex vivo expansion of umbilical cord blood. Cytotherapy (2005) 1.32
Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice. PLoS One (2011) 1.24
Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev (2008) 1.22
The therapeutic potential of stem cells. Philos Trans R Soc Lond B Biol Sci (2010) 1.15
Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl (2010) 1.14
Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol (2010) 1.08
Acute-on-chronic liver failure. Clin Mol Hepatol (2013) 1.03
Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med (2015) 0.95
Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med (2011) 0.91
Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis. J Korean Med Sci (2015) 0.91
Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials. Gastroenterol Res Pract (2015) 0.89
Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Aliment Pharmacol Ther (2014) 0.86
Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis. World J Gastroenterol (2014) 0.86
The multi-differentiation potential of peripheral blood mononuclear cells. Stem Cell Res Ther (2012) 0.85
Autologous bone marrow stem cell transplantation in patients with liver failure: a meta-analytic review. Stem Cells Dev (2015) 0.82
Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol (2013) 0.82
Prognostic value of Pugh's modification of Child-Turcotte classification in patients with cirrhosis of the liver. Panminerva Med (1992) 0.82
An update on liver transplantation: A critical review. J Autoimmun (2015) 0.81
Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis. Curr Stem Cell Res Ther (2015) 0.79
Acute-on-chronic liver failure. Clin Liver Dis (2014) 0.79
Defining acute-on-chronic liver failure: East, West or Middle ground? World J Hepatol (2015) 0.79
Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation. Adv Chronic Kidney Dis (2015) 0.77